Lv21
190 积分 2025-06-29 加入
Structural and Physicochemical Features of Oral PROTACs
1小时前
待确认
PROTAC 2.0: Expanding the frontiers of targeted protein degradation
12天前
已完结
Discovery of CFT8634, a Potent, Selective, and Orally Bioavailable Heterobifunctional Degrader of BRD9
1个月前
已完结
The IL-33 and IL-4Rα blocking antibodies itepekimab and dupilumab modulate both distinct and common inflammatory mediators in asthma
2个月前
已完结
Anti-cytokine biologics for asthma in adults
2个月前
已完结
Author Correction: The state of the art in secondary pharmacology and its impact on the safety of new medicines
2个月前
已完结
PK/PD modeling of targeted protein degraders: Charting new waters and navigating the shallows
3个月前
已完结
A Novel Inhalable Nanobody Targeting IL-4Rα for the Treatment of Asthma
3个月前
已完结
On the relationship between hERG inhibition and the magnitude of QTc prolongation: An in vitro to clinical translational analysis
3个月前
已完结
皖公网安备34019202002308
